Literature DB >> 11587045

Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes.

N J Morrish1, S L Wang, L K Stevens, J H Fuller, H Keen.   

Abstract

AIMS/HYPOTHESIS: We aimed to examine the mortality rates, excess mortality and causes of death in diabetic patients from ten centres throughout the world.
METHODS: A mortality follow-up of 4713 WHO Multinational Study of Vascular Disease in Diabetes (WHO MSVDD) participants from ten centres was carried out, causes of death were ascertained and age-adjusted mortality rates were calculated by centre, sex and type of diabetes. Excess mortality, compared with the background population, was assessed in terms of standardised mortality ratios (SMRs) for each of the 10 cohorts.
RESULTS: Cardiovascular disease was the most common underlying cause of death, accounting for 44 % of deaths in Type I (insulin-dependent) diabetes mellitus and 52 % of deaths in Type II (non-insulin-dependent) diabetes mellitus. Renal disease accounted for 21% of deaths in Type I diabetes and 11% in Type II diabetes. For Type I diabetes, all-cause mortality rates were highest in Berlin men and Warsaw women, and lowest in London men and Zagreb women. For Type II diabetes, rates were highest in Warsaw men and Oklahoma women and lowest in Tokyo men and women. Age adjusted mortality rates and SMRs were generally higher in patients with Type I diabetes compared with those with Type II diabetes. Men and women in the Tokyo cohort had a very low excess mortality when compared with the background population. CONCLUSION/
INTERPRETATION: This study confirms the importance of cardiovascular disease as the major cause of death in people with both types of diabetes. The low excess mortality in the Japanese cohort could have implications for the possible reduction of the burden of mortality associated with diabetes in other parts of the world.

Entities:  

Mesh:

Year:  2001        PMID: 11587045     DOI: 10.1007/pl00002934

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  326 in total

1.  Clinical applications of advanced lipoprotein testing in diabetes mellitus.

Authors:  Danyaal S Moin; Anand Rohatgi
Journal:  Clin Lipidol       Date:  2011-08-01

Review 2.  Cardiovascular risk associated with the metabolic syndrome.

Authors:  Robert S Lindsay; Barbara V Howard
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

Review 3.  [Management of diabetic vasculopathy in primary care: diagnosis and control].

Authors:  M Ibáñez Brillas; L Barutell Rubio; M A Jaunsolo Barrenechea
Journal:  Aten Primaria       Date:  2004-03-31       Impact factor: 1.137

Review 4.  Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communication.

Authors:  Randy S Sprague; Mary L Ellsworth
Journal:  Microcirculation       Date:  2012-07       Impact factor: 2.628

Review 5.  Vascular repair strategies in type 2 diabetes: novel insights.

Authors:  Kira Kuschnerus; Ulf Landmesser; Nicolle Kränkel
Journal:  Cardiovasc Diagn Ther       Date:  2015-10

6.  Mesenteric arterial dysfunction in the UC Davis Type 2 Diabetes Mellitus rat model is dependent on pre-diabetic versus diabetic status and is sexually dimorphic.

Authors:  Sonali Shaligram; Farjana Akther; Md Rahatullah Razan; James L Graham; Núria Roglans; Marta Alegret; Arta Gharib Parsa; Kimber L Stanhope; Peter J Havel; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2020-04-19       Impact factor: 4.432

Review 7.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

8.  Acidosis mediates recurrent hypoglycemia-induced increase in ischemic brain injury in treated diabetic rats.

Authors:  Ashish K Rehni; Vibha Shukla; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Neuropharmacology       Date:  2018-03-15       Impact factor: 5.250

9.  Sex differences in the effects of type 2 diabetes on exercise performance.

Authors:  Judith G Regensteiner; Timothy A Bauer; Amy G Huebschmann; Leah Herlache; Howard D Weinberger; Eugene E Wolfel; Jane E B Reusch
Journal:  Med Sci Sports Exerc       Date:  2015-01       Impact factor: 5.411

Review 10.  Comprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome.

Authors:  Robert E Heinl; Devinder S Dhindsa; Elliot N Mahlof; William M Schultz; Johnathan C Ricketts; Tina Varghese; Amirhossein Esmaeeli; Marc P Allard-Ratick; Anthony J Millard; Heval M Kelli; Pratik B Sandesara; Danny J Eapen; Laurence Sperling
Journal:  Can J Cardiol       Date:  2016-07-22       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.